Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) stock analysis

In our weekly check, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is graded B (A to F). Of 22 checks on debt, profit, cash flow and trend: 15 pass, warnings: 4, red flags: 3.

About Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is a Healthcare company (Biotechnology) based in China, listed on HKSE as 6990.HK.

What our checks show for 6990.HK

Red flags

• The price swings a lot: 51.4% annual volatility. Expect large ups and downs.
• The share count grew by 25.5% in 2 years: each shareholder owns a smaller slice.
• Return on capital (ROCE) is only 1%.

Warning signs

• Earnings per share fell 39.9% a year over the last 3 years.
• The net margin is only 5.8%: little room if costs rise.
• The stock is still below its previous peak.
• Pay in shares equals 43.6% of free cash flow: it dilutes shareholders.

Strengths

• Debt is low: 0.02x equity.
• The net margin rose by 2759 points over 5 years, to 5.8%.
• The gross margin is 74.6% and has risen by 109 points: pricing power is holding.
• Operating cash flow is 4.35x net profit: the profit arrives as real cash.
• Analysts expect earnings per share to grow about 200% a year over the next years.
• Analysts expect revenue to grow about 66% a year over the next years.

Similar companies

CSL.AX · REGN · MRNA · 1548.HK · 9926.HK

Questions

What grade does Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) have?

In our weekly check, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is graded B (A to F). Of 22 checks on debt, profit, cash flow and trend: 15 pass, warnings: 4, red flags: 3. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of 6990.HK stock?

This week's biggest flags for Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.: Very volatile, Share dilution, Low return on capital. In total 7 of 22 checks show a warning or a red flag.

What does Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. do?

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is a Healthcare company (Biotechnology) based in China, listed on HKSE as 6990.HK.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-31

Open the full analysis